Trials / Recruiting
RecruitingNCT06851702
Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective / prospective observational study of endocrinological adverse events in hematologic patients treated with immunological checkpoint inhibitors
Conditions
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-02-28
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06851702. Inclusion in this directory is not an endorsement.